Best Practice Guideline articleEpidemiology of neonatal encephalopathy and hypoxic–ischaemic encephalopathy
Introduction
Neonatal encephalopathy (NE) is the clinical manifestation of disordered neonatal brain function. It is a relatively common clinical condition which results in serious consequences for many of the infants including death, cerebral palsy, epilepsy and other significant cognitive, developmental and behavioural problems. The financial and human costs to infants affected, their parents, professionals and wider society are enormous. Some, but by no means all, of these costs are reflected in awards following medical litigation. In the UK about half of the cases dealt with by the National Health Service Litigation Authority (NHSLA) concern birth related adverse events; cases of NE and cerebral palsy feature heavily. In 2008 the outstanding liability of the NHSLA stood at £11.9 billion [1]. An expert group led by the Chief Medical Officer for England reported in 2000 estimating that preventing 10% of birth related adverse events would save about £20 million per year [2].
Important initial considerations in trying to describe the epidemiology of NE and hypoxic ischaemic encephalopathy (HIE) are the lack of a universally agreed definition of both these terms [3] and the need for a clear consensus in understanding of the relationship between the two that is reflected in common medical parlance. In this article we aim to provide an epidemiological background to the related papers in this edition and start by considering issues surrounding the definition of NE and HIE, how these affect incidence estimates and the identification of risk factors. Finally we consider current research needs to further our understanding of the aetiology of NE and HIE.
Section snippets
Definitions
Nelson and Leviton described NE as a “clinically defined syndrome of disturbed neurologic function in the earliest days of life in the term infant, manifested by difficulty with initiating and maintaining respiration, depression of tone and reflexes, subnormal level of consciousness, and often by seizures” [4].
Volpe defines hypoxaemia as the “diminished amount of oxygen in the blood supply” and cerebral ischaemia as the “diminished amount of blood perfusing the brain” with the latter being the
Incidence
The reported incidence of NE from different studies ranges from about 2.0 to 6.0 per 1000 live births (Table 1) [8], [9], [10], [11]. The incidence of HIE ranges from about 1.0 to 8.0, excluding the estimate from Nigeria [16] based on a single hospital series which was 26.2 per 1000 live births (Table 2) [12], [13], [14], [15], [16], [17], [18], [19], [20]. There are, however, several difficulties in interpreting these figures. With the exception of the data from Derby, UK where three
Risk factors
As with any condition, identifying the risk factors for NE and HIE is key to understanding the causal pathways and developing preventive strategies [24]. Progress has been hindered by the absence of a universally accepted case definition and a paucity of appropriately designed unbiased studies. Although clinically NE is a relatively common condition, in population terms it is relatively rare. As a consequence the case–control study design is the only realistic approach to aetiological
Future directions
The causal chain of events resulting in NE is complex, multifactorial and far from completely understood. Several promising lines of enquiry and hypotheses relating to potentially modifiable risk factors were generated by previous epidemiological studies although these studies are now well over a decade old and there have been substantial changes in clinical practice and clinical governance since their publication. Even the most recent population-based studies were carried out before improved
Acknowledgements
This paper reports on independent work which is part-funded by the Policy Research Programme in the Department of Health, England. The views expressed are not necessarily those of the Department.
References (36)
- et al.
The incidence and severity of post-asphyxial encephalopathy in full-term infants
Early Hum Dev
(1985) - et al.
Hypoxic–ischemic encephalopathy in term neonates: perinatal factors and outcome
J Pediatr
(1981) - et al.
Neonatal asphyxia. I. Relationship of obstetric and neonatal complications to neonatal mortality in 38,405 consecutive deliveries
J Pediatr
(1980) - et al.
Newborn encephalopathy in term infants: three approaches to population-based investigation
Semin Neonatol
(1997) - et al.
Major epidemiological changes in sudden infant death syndrome: a 20-year population-based study in the UK
Lancet
(2006) - The NHS Litigation Authority. Factsheet 2: financial information. Factsheet3: information on claims. London: National...
An organisation with a memory. Report of an expert group on learning from adverse events in the NHS, chaired by the Chief Medical Officer
(2000)Neonatal encephalopathy and cerebral palsy: defining the pathogenesis and pathophysiology
(2002)- et al.
How much of neonatal encephalopathy is due to birth asphyxia?
Am J Dis Child
(1991) Neurology of the newborn